CCAAT/enhancer-binding protein δ activates insulin-like growth factor- I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone

Yutaka Umayahara, Changhua Ji, Michael Centrella, Peter Rotwein, Thomas L. McCarthy

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Insulin-like growth factor-I (IGF-I) plays a key role in skeletal growth by stimulating bone cell replication and differentiation. We previously showed that prostaglandin E2 (PGE2) and other cAMP-activating agents enhanced IGF-I gene transcription in cultured primary rat osteoblasts through promoter 1, the major IGF-I promoter, and identified a short segment of the promoter, termed HS3D, that was essential for hormonal regulation of IGF-I gene expression. We now demonstrate that CCAAT/Enhancer-binding protein (C/EBP) δ is a major component of a PGE2-simulated DNA-protein complex involving HS3D and find that C/EBPδ transactivates IGF-I promoter 1 through this site. Competition gel shift studies first indicated that a core C/EBP half-site (GCAAT) was required for binding of a labeled HS3D oligomer to osteoblast nuclear proteins. Southwestern blotting and UV-cross-linking studies showed that the HS3D probe recognized a ~ 35-kDa nuclear protein, and antibody supershift assays indicated that C/EBPδ comprised most of the PGE2-activated gel-shifted complex. C/EBPδ was detected by Western immunoblotting in osteoblast nuclear extracts after treatment of cells with PGE2. An HS3D oligonucleotide competed effectively with a high affinity C/EBP site from the rate albumin gene for binding to osteoblast nuclear proteins. Cotransfection of osteoblast cell cultures with a C/EBPδ expression plasmid enhanced basal and PGE2-activated IGF-I promoter 1- luciferase activity but did not stimulate a reporter gene lacking an HS3D site. By contrast, an expression plasmid for the related protein, C/EBPβ, did not alter basal IGF-I gene activity but did increase the response to PGE2. In osteoblasts and in COS-7 cells, C/EBPδ, but not C/EBPβ, transactivated a reporter gene containing four tandem copies of HS3D fused to a minimal promoter; neither transcription factor stimulated a gene with four copies of an HS3D mutant that was unable to bind osteoblast nuclear proteins. These results identify C/EBPδ as a hormonally activated inducer of IGF-I gene transcription in osteoblasts and show that the HS3D element with IGF-I promoter 1 is a high affinity binding site for this protein.

Original languageEnglish (US)
Pages (from-to)31793-31800
Number of pages8
JournalJournal of Biological Chemistry
Volume272
Issue number50
DOIs
StatePublished - Dec 12 1997

Fingerprint

CCAAT-Enhancer-Binding Proteins
Osteoblasts
Transcription
Insulin-Like Growth Factor I
Cyclic AMP
Bone
Genes
Bone and Bones
Dinoprostone
Nuclear Proteins
Reporter Genes
Southwestern Blotting
Plasmids
Gels
Binding Sites
COS Cells
Bone Development
Luciferases
Cell culture
Oligomers

ASJC Scopus subject areas

  • Biochemistry

Cite this

CCAAT/enhancer-binding protein δ activates insulin-like growth factor- I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. / Umayahara, Yutaka; Ji, Changhua; Centrella, Michael; Rotwein, Peter; McCarthy, Thomas L.

In: Journal of Biological Chemistry, Vol. 272, No. 50, 12.12.1997, p. 31793-31800.

Research output: Contribution to journalArticle

Umayahara, Yutaka ; Ji, Changhua ; Centrella, Michael ; Rotwein, Peter ; McCarthy, Thomas L. / CCAAT/enhancer-binding protein δ activates insulin-like growth factor- I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. In: Journal of Biological Chemistry. 1997 ; Vol. 272, No. 50. pp. 31793-31800.
@article{05d9371a7c484abf9443a237cede9798,
title = "CCAAT/enhancer-binding protein δ activates insulin-like growth factor- I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone",
abstract = "Insulin-like growth factor-I (IGF-I) plays a key role in skeletal growth by stimulating bone cell replication and differentiation. We previously showed that prostaglandin E2 (PGE2) and other cAMP-activating agents enhanced IGF-I gene transcription in cultured primary rat osteoblasts through promoter 1, the major IGF-I promoter, and identified a short segment of the promoter, termed HS3D, that was essential for hormonal regulation of IGF-I gene expression. We now demonstrate that CCAAT/Enhancer-binding protein (C/EBP) δ is a major component of a PGE2-simulated DNA-protein complex involving HS3D and find that C/EBPδ transactivates IGF-I promoter 1 through this site. Competition gel shift studies first indicated that a core C/EBP half-site (GCAAT) was required for binding of a labeled HS3D oligomer to osteoblast nuclear proteins. Southwestern blotting and UV-cross-linking studies showed that the HS3D probe recognized a ~ 35-kDa nuclear protein, and antibody supershift assays indicated that C/EBPδ comprised most of the PGE2-activated gel-shifted complex. C/EBPδ was detected by Western immunoblotting in osteoblast nuclear extracts after treatment of cells with PGE2. An HS3D oligonucleotide competed effectively with a high affinity C/EBP site from the rate albumin gene for binding to osteoblast nuclear proteins. Cotransfection of osteoblast cell cultures with a C/EBPδ expression plasmid enhanced basal and PGE2-activated IGF-I promoter 1- luciferase activity but did not stimulate a reporter gene lacking an HS3D site. By contrast, an expression plasmid for the related protein, C/EBPβ, did not alter basal IGF-I gene activity but did increase the response to PGE2. In osteoblasts and in COS-7 cells, C/EBPδ, but not C/EBPβ, transactivated a reporter gene containing four tandem copies of HS3D fused to a minimal promoter; neither transcription factor stimulated a gene with four copies of an HS3D mutant that was unable to bind osteoblast nuclear proteins. These results identify C/EBPδ as a hormonally activated inducer of IGF-I gene transcription in osteoblasts and show that the HS3D element with IGF-I promoter 1 is a high affinity binding site for this protein.",
author = "Yutaka Umayahara and Changhua Ji and Michael Centrella and Peter Rotwein and McCarthy, {Thomas L.}",
year = "1997",
month = "12",
day = "12",
doi = "10.1074/jbc.272.50.31793",
language = "English (US)",
volume = "272",
pages = "31793--31800",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "50",

}

TY - JOUR

T1 - CCAAT/enhancer-binding protein δ activates insulin-like growth factor- I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone

AU - Umayahara, Yutaka

AU - Ji, Changhua

AU - Centrella, Michael

AU - Rotwein, Peter

AU - McCarthy, Thomas L.

PY - 1997/12/12

Y1 - 1997/12/12

N2 - Insulin-like growth factor-I (IGF-I) plays a key role in skeletal growth by stimulating bone cell replication and differentiation. We previously showed that prostaglandin E2 (PGE2) and other cAMP-activating agents enhanced IGF-I gene transcription in cultured primary rat osteoblasts through promoter 1, the major IGF-I promoter, and identified a short segment of the promoter, termed HS3D, that was essential for hormonal regulation of IGF-I gene expression. We now demonstrate that CCAAT/Enhancer-binding protein (C/EBP) δ is a major component of a PGE2-simulated DNA-protein complex involving HS3D and find that C/EBPδ transactivates IGF-I promoter 1 through this site. Competition gel shift studies first indicated that a core C/EBP half-site (GCAAT) was required for binding of a labeled HS3D oligomer to osteoblast nuclear proteins. Southwestern blotting and UV-cross-linking studies showed that the HS3D probe recognized a ~ 35-kDa nuclear protein, and antibody supershift assays indicated that C/EBPδ comprised most of the PGE2-activated gel-shifted complex. C/EBPδ was detected by Western immunoblotting in osteoblast nuclear extracts after treatment of cells with PGE2. An HS3D oligonucleotide competed effectively with a high affinity C/EBP site from the rate albumin gene for binding to osteoblast nuclear proteins. Cotransfection of osteoblast cell cultures with a C/EBPδ expression plasmid enhanced basal and PGE2-activated IGF-I promoter 1- luciferase activity but did not stimulate a reporter gene lacking an HS3D site. By contrast, an expression plasmid for the related protein, C/EBPβ, did not alter basal IGF-I gene activity but did increase the response to PGE2. In osteoblasts and in COS-7 cells, C/EBPδ, but not C/EBPβ, transactivated a reporter gene containing four tandem copies of HS3D fused to a minimal promoter; neither transcription factor stimulated a gene with four copies of an HS3D mutant that was unable to bind osteoblast nuclear proteins. These results identify C/EBPδ as a hormonally activated inducer of IGF-I gene transcription in osteoblasts and show that the HS3D element with IGF-I promoter 1 is a high affinity binding site for this protein.

AB - Insulin-like growth factor-I (IGF-I) plays a key role in skeletal growth by stimulating bone cell replication and differentiation. We previously showed that prostaglandin E2 (PGE2) and other cAMP-activating agents enhanced IGF-I gene transcription in cultured primary rat osteoblasts through promoter 1, the major IGF-I promoter, and identified a short segment of the promoter, termed HS3D, that was essential for hormonal regulation of IGF-I gene expression. We now demonstrate that CCAAT/Enhancer-binding protein (C/EBP) δ is a major component of a PGE2-simulated DNA-protein complex involving HS3D and find that C/EBPδ transactivates IGF-I promoter 1 through this site. Competition gel shift studies first indicated that a core C/EBP half-site (GCAAT) was required for binding of a labeled HS3D oligomer to osteoblast nuclear proteins. Southwestern blotting and UV-cross-linking studies showed that the HS3D probe recognized a ~ 35-kDa nuclear protein, and antibody supershift assays indicated that C/EBPδ comprised most of the PGE2-activated gel-shifted complex. C/EBPδ was detected by Western immunoblotting in osteoblast nuclear extracts after treatment of cells with PGE2. An HS3D oligonucleotide competed effectively with a high affinity C/EBP site from the rate albumin gene for binding to osteoblast nuclear proteins. Cotransfection of osteoblast cell cultures with a C/EBPδ expression plasmid enhanced basal and PGE2-activated IGF-I promoter 1- luciferase activity but did not stimulate a reporter gene lacking an HS3D site. By contrast, an expression plasmid for the related protein, C/EBPβ, did not alter basal IGF-I gene activity but did increase the response to PGE2. In osteoblasts and in COS-7 cells, C/EBPδ, but not C/EBPβ, transactivated a reporter gene containing four tandem copies of HS3D fused to a minimal promoter; neither transcription factor stimulated a gene with four copies of an HS3D mutant that was unable to bind osteoblast nuclear proteins. These results identify C/EBPδ as a hormonally activated inducer of IGF-I gene transcription in osteoblasts and show that the HS3D element with IGF-I promoter 1 is a high affinity binding site for this protein.

UR - http://www.scopus.com/inward/record.url?scp=0031438080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031438080&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.50.31793

DO - 10.1074/jbc.272.50.31793

M3 - Article

C2 - 9395525

AN - SCOPUS:0031438080

VL - 272

SP - 31793

EP - 31800

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 50

ER -